Connection

Michael von Bergwelt-Baildon to Animals

Back to Details
This is a "connection" page, showing publications Michael von Bergwelt-Baildon has written about Animals.
Michael von Bergwelt-Baildon
Connection Strength
0.060
Animals
  1. Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer Immunotherapy. Cancer Immunol Res. 2017 09; 5(9):730-743.
    View in: PubMed
    Score: 0.021
  2. The properties of human CD40-activated B cells as antigen-presenting cells are not affected by PGE2. Oncol Rep. 2013 Mar; 29(3):1061-5.
    View in: PubMed
    Score: 0.016
  3. A novel approach to candidemia? The potential role of checkpoint inhibition. Med Mycol. 2019 Feb 01; 57(2):151-154.
    View in: PubMed
    Score: 0.006
  4. NKT cells - New players in CAR cell immunotherapy? Eur J Haematol. 2018 Dec; 101(6):750-757.
    View in: PubMed
    Score: 0.006
  5. Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer. Cancer Res. 2018 08 01; 78(15):4270-4281.
    View in: PubMed
    Score: 0.006
  6. Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors. Immunotherapy. 2017 03; 9(5):423-433.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.